2/5/2014 8:08:09 AM
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), a leader in the development of RNAi-based therapeutics, today announced its participation in a panel discussion on RNAi therapeutics at the 16th Annual BIO CEO & Investor Conference. Douglas M. Fambrough, PhD, the company’s President and CEO, is scheduled to take part in a Therapeutic Workshop entitled: “Delivering the [RNAi] Goods” to be held on Monday, February 10th, at 10:30 a.m. Eastern Standard Time.
Help employers find you! Check out all the jobs and post your resume.
comments powered by